{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:58:58Z","timestamp":1780052338001,"version":"3.53.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.semarthrit.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T01:56:24Z","timestamp":1552096584000},"page":"296-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Characteristics of Behcet's Disease in the American Southwest"],"prefix":"10.1016","volume":"49","author":[{"given":"Maheswari","family":"Muruganandam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle A.","family":"Rolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmer L.","family":"Sibbitt, Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Suzanne","family":"Emil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monthida","family":"Fangtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur D.","family":"Bankhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2019.03.003_bib0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5152\/eurjrheum.2017.17112","article-title":"Beh\u00e7et's disease in the United States: a single center descriptive and comparative study","volume":"4","author":"Kilian","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0002","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0003","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The international criteria for behcet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0004","doi-asserted-by":"crossref","first-page":"30362","DOI":"10.3402\/jchimp.v6.30362","article-title":"Behcet's disease departs the 'Silk Road': a case report and brief review of literature with geographical comparison","volume":"6","author":"Ahmed","year":"2016","journal-title":"J Commun Hosp Intern Med Perspect"},{"issue":"4 Suppl 34","key":"10.1016\/j.semarthrit.2019.03.003_bib0005","first-page":"S53","article-title":"Prevalence of Beh\u00e7et's disease in rural western Turkey: a preliminary report","volume":"22","author":"Cakir","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3346\/jkms.2002.17.6.784","article-title":"The clinical features of Behcet's disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001","volume":"17","author":"Chang","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0007","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Behcet's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0008","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","article-title":"Clinical features of chinese patients with Behcet's disease","volume":"115","author":"Yang","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.03.003_bib0009","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0011","unstructured":"Moss-Adams, L.L.P. University of New Mexico Hospital report of independent auditors and financial statement with supplemental information. June 30, 2016 and 2015, https:\/\/hsc.unm.edu\/health\/about\/financial-reports\/doc\/audited-2016-unmh.pdf Assessed February 18, 2019."},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0012","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3899\/jrheum.131227","article-title":"Behcet syndrome manifestations and activity in the United States versus Turkey \u2013 a cross-sectional cohort comparison","volume":"41","author":"Sibley","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0013","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","article-title":"Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases","volume":"45","author":"Sarica-Kucukoglu","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0014","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1346-8138.2005.tb00760.x","article-title":"Sensitivity and specificity of different diagnostic criteria for Behcet's disease in a group of Turkish patients","volume":"32","author":"Dervis","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0015","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00296-013-2830-0","article-title":"Systemic involvements and preferred treatments in a large cohort of Behcet's disease","volume":"33","author":"Yilmaz","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/09546634.2015.1054781","article-title":"Clinical features of Beh\u00e7et's disease: a retrospective chart review of 26 patients","volume":"27","author":"Davari","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0017","series-title":"National hospital ambulatory medical care Survey: 2011 outpatient department summary tables","year":"2011"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0018","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/art.24149","article-title":"Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration","volume":"58","author":"Mahr","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.03.003_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.rdc.2013.02.010","article-title":"Beh\u00e7et's syndrome","volume":"39","author":"Hatemi","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","article-title":"Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease","volume":"42","author":"Tursen","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2003.18.2.231","article-title":"Influence of sex on patients with Behcet's disease in Korea","volume":"18","author":"Bang","year":"2003","journal-title":"J Korean Med Sci"},{"issue":"Suppl 108(6)","key":"10.1016\/j.semarthrit.2019.03.003_bib0022","first-page":"43","article-title":"Beh\u00e7et's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status","volume":"35","author":"Senusi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.03.003_bib0023","first-page":"1215","article-title":"Cigarette smoking and disease activity in systemic lupus erythematosus","volume":"30","author":"Ghaussy","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0024","doi-asserted-by":"crossref","unstructured":"Cabacungan RJ, Qualls CR, Sibbitt WL Jr, Hayward WA, Gibb JI, Kettwich SD, Fields RA, Emil NS, Fangtham M, Bankhurst AD. Opioid use and mortality in systemic lupus erythematosus. bioRxiv 2018. doi:10.1101\/395343.","DOI":"10.1101\/395343"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0025","doi-asserted-by":"crossref","unstructured":"Jalil BA, Qualls CR, Cabacungan RJ, Sibbitt WL Jr, Gibb JI, Noronha LE, Fields RA, Emil NS, Fangtham M, Bankhurst AD. Medical nonaderence, cannabis use, and renal outcome in systemic lupus erythematosus. bioRxiv 2018. doi:10.1101\/389973.","DOI":"10.1101\/389973"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.03.003_bib0026","first-page":"471","article-title":"Beh\u00e7et's disease, hospital-based prevalence and manifestations in the Rotterdam area","volume":"73","author":"Kappen","year":"2015","journal-title":"Neth J Med"},{"issue":"2-3","key":"10.1016\/j.semarthrit.2019.03.003_bib0027","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.imlet.2004.03.017","article-title":"Class I and class II MHC polymorphisms in Mexican patients with Beh\u00e7et's disease","volume":"93","author":"Soto-Vega","year":"2004","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.03.003_bib0028","first-page":"29","article-title":"Beh\u00e7et's disease. Report of twelve patients in the Mexican population","volume":"33","author":"Lavalle Montalvo","year":"1981","journal-title":"Rev Invest Clin"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.03.003_bib0029","first-page":"325","article-title":"Association of Beh\u00e7et's syndrome with HLA-B5 in the Mexican mestizo population","volume":"8","author":"Lavalle","year":"1981","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0030","first-page":"52","article-title":"Anticoagulation in Beh\u00e7et related intrathoracic vasculitis","volume":"25","author":"Nokes","year":"2018","journal-title":"Respir Med Case Rep"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.03.003_bib0031","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00251-002-0522-0","article-title":"Distribution of HLA-B alleles in Mexican Amerindian populations","volume":"54","author":"Vargas-Alarc\u00f3n","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0032","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RHU.0b013e31823a46ed","article-title":"Beh\u00e7et disease: clinical features and management in a Brazilian tertiary hospital","volume":"17","author":"Oliveira","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"6 Suppl 115","key":"10.1016\/j.semarthrit.2019.03.003_bib0033","first-page":"40","article-title":"Venous thrombosis and relapses in patients with Beh\u00e7et's disease. Descriptive analysis from Spanish network of Beh\u00e7et's disease (REGEB cohort)","volume":"36","author":"Rodr\u00edguez-Carballeira","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.03.003_bib0034","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00296-012-2530-1","article-title":"The prevalence of fibromyalgia in patients with Beh\u00e7et's disease and its relation with diseaseactivity","volume":"33","author":"Melikoglu","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.03.003_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2049463717701393","article-title":"Fibromyalgia in Beh\u00e7et's disease: a narrative review","volume":"11","author":"Jobanputra","year":"2017","journal-title":"Br J Pain"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.03.003_bib0036","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar4328","article-title":"HLA and non-HLA genes in Beh\u00e7et's disease: a multicentric study in the Spanish population","volume":"15","author":"Montes-Cano","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0037","article-title":"The HLA-B*51 Allele is strongly associated with beh\u00e7et disease in an argentinean population","author":"Mu\u00f1oz","year":"2018","journal-title":"Reumatol Clin"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.03.003_bib0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1756-185X.12691","article-title":"Adult Behcet's disease in Iran: analysis of 6075 patients","volume":"19","author":"Davatchi","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.03.003_bib0039","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1399-0039.2001.580304.x","article-title":"Comparative analysis of the association of HLA-B*51 suballeles with Beh\u00e7et's disease in patients of German and Turkish origin","volume":"58","author":"K\u00f6tter","year":"2001","journal-title":"Tissue Antigens"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.03.003_bib0040","first-page":"391","article-title":"Familial Beh\u00e7et's disease","volume":"1","author":"Akpolat","year":"1992","journal-title":"Eur J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.03.003_bib0041","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.2009.01381.x","article-title":"Molecular variation at the HLA-A, B, C, DRB1, DQA1, and DQB1 loci in full heritage American Indians in Arizona: private haplotypes and their evolution","volume":"74","author":"Williams","year":"2009","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.03.003_bib0042","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ard.53.11.755","article-title":"HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies","volume":"53","author":"Vargas-Alarc\u00f3n","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0043","unstructured":"Middelton D, Menchaca L, Rood H. Komerofsky R. New allele frequency database: http:\/\/www.allelefrequencies.net Assessed February 20, 2019."},{"issue":"3","key":"10.1016\/j.semarthrit.2019.03.003_bib0044","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.03.003_bib0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1399-0039.1999.530211.x","article-title":"A novel HLA allele, HLA-B*5113, identified in the Kolla Amerindians of North-West Argentina","volume":"53","author":"Scott","year":"1999","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.03.003_bib0046","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-0039.1997.tb02868.x","article-title":"Further diversification of the HLA-B locus in Central American Amerindians: new B*39 and B*51 alleles in the Kuna of Panama","volume":"50","author":"Iwanaga","year":"1997","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.03.003_bib0047","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ana.410310618","article-title":"Idiopathic childhood stroke is associated with human leukocyte antigen (HLA)-B51","volume":"31","author":"Mintz","year":"1992","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.03.003_bib0048","first-page":"185","article-title":"Combination therapy with infliximab and methotrexate in recalcitrant mucocutaneous Beh\u00e7et disease","volume":"89","author":"Chan","year":"2012","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.03.003_bib0049","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","article-title":"Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et's disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.03.003_bib0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Beh\u00e7et's disease: multicentre retrospective study","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.03.003_bib0051","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09273948.2016.1239746","article-title":"Efficacy of infliximab for early remission induction in refractory uveoretinitis associated with Beh\u00e7et disease: a 2-year follow-up study","volume":"25","author":"Keino","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0052","first-page":"95","article-title":"Intravenous corticosteroid megadose treatment in ocular Beh\u00e7et disease","volume":"262","author":"Postelmans","year":"1996","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.03.003_bib0053","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-128-6-199803150-00011","article-title":"Beh\u00e7et disease and the emergence of thalidomide","volume":"128","author":"Ehrlich","year":"1998","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.03.003_bib0054","first-page":"348","article-title":"Rapid, complete and sustained response to corticosteroids and pulse cyclophosphamidetherapy in a patient with beh\u00e7et and central nervous disease","volume":"7","author":"Nu\u00f1ez-Sotelo","year":"2012","journal-title":"Maedica (Buchar)"},{"issue":"4 Suppl 67","key":"10.1016\/j.semarthrit.2019.03.003_bib0055","first-page":"S64","article-title":"Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et's disease with parenchymal involvement: presentation of four cases","volume":"29","author":"Shugaiv","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.03.003_bib0056","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/tjo.tjo_99_17","article-title":"Interferon-\u03b12a treatment for refractory Beh\u00e7et's disease","volume":"8","author":"Lai","year":"2018","journal-title":"Taiwan J Ophthalmol"},{"issue":"3-4","key":"10.1016\/j.semarthrit.2019.03.003_bib0057","first-page":"238","article-title":"Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's disease with different organ involvement: a case series","volume":"18","author":"Cantarini","year":"2016","journal-title":"Isr Med Assoc J"},{"issue":"16","key":"10.1016\/j.semarthrit.2019.03.003_bib0058","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et's syndrome \u2013 a phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.03.003_bib0059","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/MCG.0b013e3182431d56","article-title":"Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease","volume":"46","author":"Jung","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.03.003_bib0060","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00296-009-1305-9","article-title":"Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers","volume":"31","author":"Appenzeller","year":"2011","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.03.003_bib0061","first-page":"158","article-title":"Azathioprine for glucocorticoid resistant noninfectious uveitis","volume":"93","author":"Mili-Boussen","year":"2015","journal-title":"Tunis Med"},{"key":"10.1016\/j.semarthrit.2019.03.003_bib0062","first-page":"241","article-title":"Intermittent hydarthrosis of the knee as a component in the picture of Behcet's disease. Apparent cure of the recurrent articular effusion using chloroquine","volume":"1","author":"Louyot","year":"1962","journal-title":"Ann Med Nancy"},{"issue":"14","key":"10.1016\/j.semarthrit.2019.03.003_bib0063","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1177\/0961203318811598","article-title":"Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort","volume":"27","author":"Gonz\u00e1lez-Echavarri","year":"2018","journal-title":"Lupus"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218307911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218307911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:59:44Z","timestamp":1758733184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218307911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0049017218307911"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.03.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Behcet's Disease in the American Southwest","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}